JP2017515473A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017515473A5 JP2017515473A5 JP2016565470A JP2016565470A JP2017515473A5 JP 2017515473 A5 JP2017515473 A5 JP 2017515473A5 JP 2016565470 A JP2016565470 A JP 2016565470A JP 2016565470 A JP2016565470 A JP 2016565470A JP 2017515473 A5 JP2017515473 A5 JP 2017515473A5
- Authority
- JP
- Japan
- Prior art keywords
- chain variable
- variable region
- sequence
- antibody
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461987929P | 2014-05-02 | 2014-05-02 | |
| US61/987,929 | 2014-05-02 | ||
| PCT/EP2015/059633 WO2015166105A2 (en) | 2014-05-02 | 2015-05-02 | Ion channel modulators and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019166248A Division JP2020018307A (ja) | 2014-05-02 | 2019-09-12 | イオンチャネルモジュレーターおよびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017515473A JP2017515473A (ja) | 2017-06-15 |
| JP2017515473A5 true JP2017515473A5 (enExample) | 2018-04-19 |
Family
ID=53055033
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016565470A Pending JP2017515473A (ja) | 2014-05-02 | 2015-05-02 | イオンチャネルモジュレーターおよびその使用 |
| JP2019166248A Pending JP2020018307A (ja) | 2014-05-02 | 2019-09-12 | イオンチャネルモジュレーターおよびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019166248A Pending JP2020018307A (ja) | 2014-05-02 | 2019-09-12 | イオンチャネルモジュレーターおよびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10654926B2 (enExample) |
| EP (2) | EP4001310A3 (enExample) |
| JP (2) | JP2017515473A (enExample) |
| AU (1) | AU2015254558B2 (enExample) |
| BR (1) | BR112016025450A2 (enExample) |
| CA (1) | CA2946669A1 (enExample) |
| ES (1) | ES2899754T3 (enExample) |
| WO (1) | WO2015166105A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11266690B2 (en) * | 2018-02-01 | 2022-03-08 | Nanjing Iaso Biotherapeutics Co., Ltd. | Chimeric antigen receptor (CAR) binding to BCMA, and uses thereof |
| US12145991B2 (en) | 2018-11-02 | 2024-11-19 | Unm Rainforest Innovations | Therapeutic antibody fragments, methods of making, and methods of use |
| WO2020186158A2 (en) * | 2019-03-13 | 2020-09-17 | Ulmert Hans David Staffan | Prame binding molecules and uses thereof |
| US12123814B1 (en) * | 2019-06-14 | 2024-10-22 | Pierce Biotechnology, Inc. | G- protein coupled receptor extraction formulations |
| WO2021041194A1 (en) * | 2019-08-23 | 2021-03-04 | Unm Rainforest Innovations | Non-opioid compositions and therapies for pain management |
| MX2022005983A (es) * | 2019-11-18 | 2022-09-07 | Janssen Biotech Inc | Receptores del antígeno quimérico anti-cd79, células car-t, y usos de estos. |
| EP4228682A4 (en) * | 2020-10-16 | 2024-11-13 | Senti Biosciences, Inc. | Chimeric receptors and methods of use thereof |
| CN114685657B (zh) * | 2020-12-31 | 2024-08-16 | 康诺亚生物医药科技（成都）有限公司 | 一种功能增强型抗体阻断剂的开发及其应用 |
| WO2023114962A1 (en) * | 2021-12-16 | 2023-06-22 | Unm Rainforest Innovations | Humanized non-opioid composition and therapies for pain management |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| EP0272253A4 (en) | 1986-03-07 | 1990-02-05 | Massachusetts Inst Technology | METHOD FOR IMPROVING GLYCOPROTE INSTABILITY. |
| AU600575B2 (en) | 1987-03-18 | 1990-08-16 | Sb2, Inc. | Altered antibodies |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| US6030613A (en) | 1995-01-17 | 2000-02-29 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
| US6242216B1 (en) * | 1997-11-14 | 2001-06-05 | Abbott Laboratories | Nucleic acids encoding a functional human purinoreceptor P2X2 and P2X4, and methods of production and use thereof |
| AUPP991199A0 (en) * | 1999-04-21 | 1999-05-13 | University Of Sydney, The | Methods for diagnosing pre-cancerous and cancerous conditions |
| AUPR201500A0 (en) * | 2000-12-11 | 2001-01-11 | Biosceptre Pty Ltd | Methods for identifying pre-neoplastic and neoplastic states in mammals |
| US20050074819A1 (en) * | 2003-10-01 | 2005-04-07 | Japan Health Sciences Foundation | Screening method of drug for treatment of neuropathic pain |
| US20080287467A1 (en) * | 2004-05-06 | 2008-11-20 | Gen Tamura | Therapeutic Agent for Respiratory Diseases |
| WO2010093061A1 (ja) | 2009-02-16 | 2010-08-19 | 日本ケミファ株式会社 | ジアゼピンジオン誘導体 |
| UA118028C2 (uk) * | 2013-04-03 | 2018-11-12 | Рош Глікарт Аг | Біспецифічне антитіло, специфічне щодо fap і dr5, антитіло, специфічне щодо dr5, і спосіб їх застосування |
-
2015
- 2015-05-02 AU AU2015254558A patent/AU2015254558B2/en active Active
- 2015-05-02 CA CA2946669A patent/CA2946669A1/en not_active Abandoned
- 2015-05-02 WO PCT/EP2015/059633 patent/WO2015166105A2/en not_active Ceased
- 2015-05-02 EP EP21191978.2A patent/EP4001310A3/en not_active Withdrawn
- 2015-05-02 EP EP15720962.8A patent/EP3137501B1/en active Active
- 2015-05-02 JP JP2016565470A patent/JP2017515473A/ja active Pending
- 2015-05-02 ES ES15720962T patent/ES2899754T3/es active Active
- 2015-05-02 US US15/308,294 patent/US10654926B2/en active Active
- 2015-05-02 BR BR112016025450A patent/BR112016025450A2/pt not_active Application Discontinuation
-
2019
- 2019-09-12 JP JP2019166248A patent/JP2020018307A/ja active Pending
-
2020
- 2020-04-06 US US16/840,910 patent/US20200247885A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017515473A5 (enExample) | ||
| JP2012525128A5 (enExample) | ||
| ES2983252T3 (es) | Tratamiento de las infecciones polibacterianas | |
| JP2020505017A (ja) | 抗ｐｄ−１モノクローナル抗体、その製造方法及び用途 | |
| EP3178847B1 (en) | Anti-tnf-alpha fully human monoclonal antibodies with low immunogenicity and application thereof | |
| JP2017501711A5 (enExample) | ||
| CN117024583A (zh) | 抗N3pGlu淀粉状蛋白β肽抗体及其用途 | |
| JP7032534B2 (ja) | ヒトｉｌ－５に結合するモノクローナル抗体、その製造方法および治療薬 | |
| KR20150080033A (ko) | 골관절염 및 통증의 치료 방법 | |
| RU2010120879A (ru) | Антитела против g-белка распираторно-синцитиального вируса (rsv) | |
| WO2021052461A1 (zh) | 抗α-溶血素的抗体及其应用 | |
| JP2010527939A5 (enExample) | ||
| MX2025002112A (es) | Composiciones de proteina de fusion recombinante neuregulina-1 (nrg-1) humana y metodos para su uso | |
| JP2022177132A (ja) | 精神障害の治療 | |
| JP7110095B2 (ja) | 院内肺炎を予防または治療する方法 | |
| JP2018529661A5 (enExample) | ||
| JP2015515492A5 (enExample) | ||
| JP2024149479A (ja) | 黄熱を処置するための方法および組成物 | |
| JP6556758B2 (ja) | 黄色ブドウ球菌特異的抗体、それを用いた治療方法及び検出方法 | |
| TWI745962B (zh) | 測定投予至人類個體之包括雙-v-區類抗體蛋白或其片段的劑量是否在人類個體中與il-4或il-13特異性結合之方法 | |
| TWI869137B (zh) | 廣譜新型冠狀病毒的雙特異性抗體 | |
| ES2985731T3 (es) | Tratamiento de exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica mediante antagonismo de IL-20R | |
| JP6882440B2 (ja) | 抗ｉｌ４−ｉｌ１３二重特異性抗体 | |
| WO2024020236A2 (en) | Monoclonal antibodies that interfere with iron uptake | |
| WO2022068894A1 (zh) | 同时靶向pd-l1和vegf的双功能分子及其医药用途 |